Article PDF
References
Zenobi PD, Holzmann P, Glatz Y, Riesen WF, Froesch ER (1993) Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I. Diabetologia 36:465–469
Urena P, Bonnardeaux A, Eckardt K-W, Kurtz A, Drueke TB (1992) Insulin-like growth factor I: a modulator of erythropoesis in uraemic patients? Nephrol Dial Transplant 7:40–44
Kurtz A, Zapf J, Eckardt K-W, Clemons G, Froesch ER, Bauer C (1988) Insulin-like growth factor I stimulates erythropoesis in hypophysectomised rats. Proc Natl Acad Sci USA 85:7825–7829
Quin JD, Fisher BM, Paterson KR, Inoue A, Beastall GH, MacCuish AC (1990) Effect of acute administration of recombinant insulin-like growth factor I in a patient with the Mendenhall syndrome. N Engl J Med 323:1425–1426
Quin JD, Smith KA, Beastall GH, MacCuish AC (1993) Effect of recombinant insulin-like growth factor I infusion on lipids and apolipoproteins in extreme insulin resistance. J Endocrinol 137 [Suppl]: P47 (Abstract)
Kuzuya H, Matsuura N, Sakamoto M et al. (1993) Trial of insulin-like growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes 42: 696–705
Tonshoff B, Mehls O, Heinrich U, Blum WF, Ranke MB, Shauer A (1990) Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease. J Pediatr 116:561–566
Additional information
Senior Registrar in Diabetes/Endocrinology, Royal Sussex Country Hospital, Brighton, Sussex, UK
Rights and permissions
About this article
Cite this article
Quin, J.D., Miell, J.P., Smith, K. et al. Effect of insulin-like growth factor-1 therapy on erythropoetin concentrations in extreme insulin resistance. Diabetologia 37, 439 (1994). https://doi.org/10.1007/BF00408484
Issue Date:
DOI: https://doi.org/10.1007/BF00408484